We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

31 hedge funds and large institutions have $5.58M invested in vTv Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% less ownership

Funds ownership: 0.18% → 0.14% (-0.04%)

26% less funds holding

Funds holding: 42 → 31 (-11)

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

46% less capital invested

Capital invested by funds: $10.3M → $5.58M (-$4.73M)

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
31
Holders Change
-11
Holders Change %
-26.19%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
11
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$285K
2
GCP
GSA Capital Partners
United Kingdom
+$218K
3
VF
Virtu Financial
New York
+$192K
4
Rafferty Asset Management
Rafferty Asset Management
New York
+$103K
5
Morgan Stanley
Morgan Stanley
New York
+$79.4K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$554K
2
Marshall Wace
Marshall Wace
United Kingdom
-$469K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$414K
4
Two Sigma Investments
Two Sigma Investments
New York
-$337K
5
Millennium Management
Millennium Management
New York
-$279K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.69M +$5.28K +70 +0.2%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$531K +$285K +3,786 +77%
WAG
3
Winthrop Advisory Group
Massachusetts
$409K – – –
CIM
4
CIM Investment Management
Pennsylvania
$271K – – –
Millennium Management
5
Millennium Management
New York
$225K -$279K -3,696 -50%
Citadel Advisors
6
Citadel Advisors
Florida
$198K +$2.79K +37 +1%
GCP
7
GSA Capital Partners
United Kingdom
$177K +$218K +2,887 New
VF
8
Virtu Financial
New York
$156K +$192K +2,542 New
BlackRock
9
BlackRock
New York
$150K +$1.58K +21 +0.9%
Vontobel Holding
10
Vontobel Holding
Switzerland
$123K – – –
Morgan Stanley
11
Morgan Stanley
New York
$121K +$79.4K +1,053 +115%
State Street
12
State Street
Massachusetts
$94K -$54.3K -720 -32%
Rafferty Asset Management
13
Rafferty Asset Management
New York
$83K +$103K +1,363 New
TRCT
14
Tower Research Capital (TRC)
New York
$63K +$3.77K +50 +5%
Northern Trust
15
Northern Trust
Illinois
$62K – – –
Goldman Sachs
16
Goldman Sachs
New York
$37K -$16.9K -224 -27%
Marshall Wace
17
Marshall Wace
United Kingdom
$36K -$469K -6,221 -91%
V
18
Veritable
Delaware
$32K – – –
TSS
19
Two Sigma Securities
New York
$26K +$32.2K +427 New
EGM
20
Engineers Gate Manager
New York
$24K -$17.8K -236 -37%
ECM
21
ExodusPoint Capital Management
New York
$21K +$26.2K +348 New
GPFA
22
Game Plan Financial Advisors
Ohio
$20K – – –
CSS
23
Cubist Systematic Strategies
Connecticut
$17K -$5.8K -77 -22%
Osaic Holdings
24
Osaic Holdings
Arizona
$3K -$2.79K -37 -42%
Wells Fargo
25
Wells Fargo
California
$3K +$75 +1 +2%
1
2

VTVT Hedge Fund Activity: Q3 2021 in Review

31 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2021, worth a combined $5.58M — down 46% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of VTVT and 6 opened new positions — a net loss of 11 holders — while 11 trimmed existing stakes and 7 added.

The largest buyer was Geode Capital Management, adding an estimated $285K. The largest seller was HRT Financial, exiting entirely with an estimated $554K sold.

  • 31 institutional investors held vTv Therapeutics (VTVT) as of Q3 2021, down from 42 in Q2 2021.
  • Funds reported $5.58M of vTv Therapeutics stock for Q3 2021, down 46% quarter-over-quarter.
  • 6 funds opened new vTv Therapeutics positions in Q3 2021 and 17 closed out, a net change of -11 holders.
  • The largest vTv Therapeutics buyer in Q3 2021 was Geode Capital Management, an estimated $285K added.
  • The largest vTv Therapeutics seller in Q3 2021 was HRT Financial, an estimated $554K sold.

Based on aggregated 13F filings for Q3 2021.